BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 14, 2003
View Archived Issues
Epimmune Plans Acquisition Of Anosys For Synergistic Platform
The San Diego-based company entered a preliminary merger agreement with Anosys Inc. to create a combined entity focused on immunotherapeutics and products to treat cancer and infectious diseases. (BioWorld Today)
Read More
RAC Says Stopping Trials With Retroviral Vectors Not Warranted
Read More
Trans-Atlantic Genomic Search For Leprosy Susceptibility Gene Heats Up Over Chromosomal Candidates
Read More
Albany Molecular Expands Via Lilly Deal, Organichem Purchase
Read More
Holiday Notice
Read More
Correction
Read More
Other News To Note
Read More
